How big is the Vaccine Contract Manufacturing Market?

The Vaccine Contract Manufacturing Market size is expected to reach USD 3.51 billion in 2024 and grow at a CAGR of 11.18% to reach USD 5.98 billion by 2029. Read More

What is the current Vaccine Contract Manufacturing Market size?

In 2024, the Vaccine Contract Manufacturing Market size is expected to reach USD 3.51 billion. Read More

Who are the key players in Vaccine Contract Manufacturing Market?

Ajinomoto Bio-Pharma Services, Curia Global, Charles River Laboratories International Inc., Emergent BioSolutions Inc. and IDT Biologika GmbH are the major companies operating in the Vaccine Contract Manufacturing Market. Read More

Which is the fastest growing region in Vaccine Contract Manufacturing Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Vaccine Contract Manufacturing Market?

In 2024, the North America accounts for the largest market share in Vaccine Contract Manufacturing Market. Read More

What years does this Vaccine Contract Manufacturing Market cover, and what was the market size in 2023?

In 2023, the Vaccine Contract Manufacturing Market size was estimated at USD 3.16 billion. The report covers the Vaccine Contract Manufacturing Market historical market size for years: 2021, 2022 and 2023. The report also forecasts the Vaccine Contract Manufacturing Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Vaccine Contract Manufacturing Market

Vaccine Contract Manufacturing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Vaccine Contract Manufacturing Market Trends and the Market is Segmented by Vaccine Type (Inactivated Vaccines, Live-attenuated Vaccines, RNA Vaccines, Subunit Vaccines, and Toxoid-based Vaccines), Process (Downstream (Analytical and QC Studies, Fill and Finish, Packaging, Other Downstream Processes) and Upstream (Bacterial Expression Systems, Baculovirus/Insect Expression Systems, Mammalian Expression Systems, Yeast Expression Systems, Other Upstream Processes)), Scale of Operations (Preclinical, Clinical, and Commercial), End Use (Human Use and Veterinary), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above-mentioned segments.

Vaccine Contract Manufacturing Industry Overview

The vaccine contract manufacturing market is fragmented and competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies which are currently dominating the market are Ajinomoto Bio-Pharma Services, Curia Global, Catalent, Charles River Laboratories International Inc., Emergent BioSolutions Inc., CJ CheilJedang Corporation (Batavia Biosciences), Gedeon Richter (Richter-Helm BioLogics, Fujifilm Holdings Corporation, ICON PLC, IDT Biologika GmbH, Lonza Group AG, and Recipharm AB, among others.